Equities

Kobayashi Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Kobayashi Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)5,297.00
  • Today's Change-103.00 / -1.91%
  • Shares traded222.90k
  • 1 Year change-8.29%
  • Beta-0.0148
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kobayashi Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of healthcare products, daily necessities, and products such as heat packs. The Company operates through two segments including domestic and international. Healthcare products include anmerutsu, eyebon, inochinohaha, naishitoru, and oral hygiene products. Daily necessities include air fresheners/deodorizers, sundries, and food products. The Company also engages in transportation services, the manufacture and sale of synthetic resin containers, real estate management, and advertising planning and production.

  • Revenue in JPY (TTM)163.18bn
  • Net income in JPY11.53bn
  • Incorporated1919
  • Employees3.62k
  • Location
    Kobayashi Pharmaceutical Co LtdKDX Kobayashi Doshomachi Bldg.4-4-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
  • Phone+81 662311144
  • Websitehttps://www.kobayashi.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Milbon Co Ltd52.15bn3.31bn86.35bn1.19k26.291.8415.391.66101.66101.661,602.741,451.870.95341.8512.0043,897,650.006.049.656.9511.2562.4464.316.3410.792.365,454.000.0052.517.447.1925.392.1211.029.46
Earth Corp177.37bn5.26bn110.61bn4.88k20.641.4410.790.6236241.23241.238,133.323,447.351.233.465.9636,361,830.003.894.067.437.8841.8940.503.162.860.8825--0.021155.006.91-2.23-15.2922.6914.823.37
Arata Corp997.99bn9.59bn112.50bn2.92k10.870.86527.800.1127287.04287.0429,863.033,605.963.1319.227.85341,426,300.003.013.266.106.999.729.870.96121.021.2453.980.245927.804.464.370.34887.5711.5719.14
Mandom Corp78.25bn1.93bn152.77bn2.59k74.022.0525.321.9542.7642.761,733.681,543.080.80752.657.0330,248,550.001.901.152.421.4545.2143.292.361.543.03--0.0012147.824.03-1.41-28.53-16.00-28.25-8.39
Noevir Holdings Co Ltd63.39bn8.38bn161.05bn1.35k19.223.3920.632.54245.28245.281,855.831,389.760.89632.505.9246,815,360.0012.099.8214.2511.2267.0167.2513.4812.593.52--0.014899.801.414.540.75287.418.862.33
MTG Co Ltd98.81bn7.93bn172.69bn1.51k21.513.3116.961.75199.95199.952,490.431,298.261.482.1211.6665,264,200.0011.637.2715.449.1962.7563.117.866.041.24--0.067913.0837.4923.18248.1439.0738.11--
Pigeon Corp108.66bn9.98bn202.80bn3.07k19.982.5813.541.8783.4483.44908.45646.861.063.406.2135,440,310.009.999.0712.4711.1550.2448.499.439.202.88--0.00102.2410.280.817212.77-6.22-10.951.66
PALTAC Corp1.21tn22.11bn307.95bn2.28k13.901.0310.800.2539357.45357.4519,617.264,835.222.3320.515.29531,233,000.004.254.387.307.717.537.621.821.841.49--0.0026.623.142.5710.79-2.09-37.948.45
Pola Orbis Holdings Inc169.97bn9.99bn321.71bn4.02k31.131.9217.511.8945.1045.10767.49730.110.87671.7910.3842,269,580.005.154.555.895.2081.0782.335.885.433.21--0.0002121.71-1.70-4.98-3.92-13.965.46-8.25
Kose Holdings Corp324.54bn7.49bn353.62bn8.13k44.501.2316.721.09131.16131.165,686.874,739.060.87811.337.0539,919,190.002.35--3.01--68.68--2.68--2.30--0.0346--7.44---35.61------
Kobayashi Pharmaceutical Co Ltd163.18bn11.53bn421.47bn3.62k34.811.8920.962.58155.13155.132,195.072,852.310.63752.654.0945,139,420.004.517.075.378.8951.3455.527.0711.022.40--0.003338.66-4.530.9006-50.50-12.0640.856.92
Lion Corp416.73bn29.35bn480.39bn7.65k16.211.558.991.15105.91105.911,504.201,105.800.88563.876.0154,445,910.006.955.379.908.3545.6846.857.856.291.40--0.086132.102.533.5144.950.6131-1.885.15
Data as of Feb 06 2026. Currency figures normalised to Kobayashi Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

22.64%Per cent of shares held by top holders
HolderShares% Held
Oasis Management Co. Ltd.as of 22 Dec 202510.19m13.06%
The Vanguard Group, Inc.as of 07 Jan 20261.93m2.47%
Nomura Asset Management Co., Ltd.as of 08 Jan 20261.78m2.28%
Amova Asset Management Co., Ltd.as of 09 Jan 2026804.20k1.03%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2025775.10k0.99%
Norges Bank Investment Managementas of 30 Jun 2025731.24k0.94%
BlackRock Fund Advisorsas of 09 Jan 2026698.10k0.89%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 2026419.05k0.54%
Charles Schwab Investment Management, Inc.as of 08 Jan 2026172.22k0.22%
BlackRock Investment Management (UK) Ltd.as of 30 Nov 2025171.37k0.22%
More ▼
Data from 30 Jun 2025 - 19 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.